Mometasone Furoate
Who holds supplier records for Mometasone Furoate? 24 organisations hold a current record for Mometasone Furoate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 21 of them hold a valid EU Certificate of Suitability (22 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), Italy (4), Israel (2), China (2) and 4 other countries (4); not recorded for 5.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Mometasone Furoate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mometasone-furoate
Reading the evidence
- 24 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Mometasone Furoate expires 24 Nov 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (24)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Mometasone Furoate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI PHARMALABS LIMITEDIndiaCEPActive DMF 21334, 27956, 33174 +1 · latest filing Sept 2018
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 30852, 31076, 35686 · latest filing Jul 2021
- STERLING SPAItalyCEP Company GMP cert on recordActive DMF 27022, 16648, 44490 · latest filing Jul 2026
- BREATHGREEN PHARMACEUTICAL CO LTDCEPActive DMF 39302, 39303 · latest filing Dec 2023
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 20969, 41355, 27244 · latest filing Mar 2025
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 22319, 33446 · latest filing Mar 2019
- NEWCHEM SPAItalyCEP Company GMP cert on recordActive DMF 42344, 21993 · latest filing Oct 2025
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 20684, 19781, 25448 · latest filing Oct 2011
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 15187, 23888 · latest filing Jun 2010
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTDActive DMF 44204, 44205 · latest filing May 2026
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaActive DMF 31362, 34112 · latest filing Dec 2019
- Aurisco Pharmaceutical Co.,ltdChinaCEP Company GMP cert on recordActive DMF 21141 · latest filing Dec 2007
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 23916 · latest filing Jun 2010
- HENAN LIHUA PHARMACEUTICAL CO LTDCEPActive DMF 36182 · latest filing Nov 2021
- Hovione FarmaCiencia SAPortugalCEP Company GMP cert on recordActive DMF 25987 · latest filing Apr 2012
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 35009 · latest filing Jul 2020
- SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysiaCEPActive DMF 26153 · latest filing Jun 2012
- TAPI NL BVNetherlandsCEPActive DMF 15063 · latest filing Sept 2000
- Taro Pharmaceutical Industries Ltd.IsraelCEP Company GMP cert on recordActive DMF 23502 · latest filing May 2010
- HALCYON LABS PRIVATE LTDIndiaActive DMF 21654 · latest filing May 2008
- SHAKTI LIFESCIENCE PRIVATE LIMITEDIndiaCEP
- SHANDONG SIRUI PHARMACEUTICAL CO LTDCEP
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEP
- AVIK PHARMACEUTICAL LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (22)
Certificates of Suitability on the EDQM register for Mometasone Furoate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 39 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2026-174 - Rev 00 Mometasone furoate monohydrate, Micronised | Sept 2026 | — |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | CEP 2019-268 - Rev 01 Mometasone furoate | Sept 2026 | Inspected Oct 2025 Italy |
| TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa | IL | CEP 2010-349 - Rev 04 Mometasone furoate, Micronised | Jul 2026 | Inspected Feb 2025 Israel |
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2007-194 - Rev 05 Mometasone furoate, Micronised | Apr 2026 | Inspected Mar 2026 Germany |
| STERLING S.p.A. Corciano | IT | CEP 2025-557 - Rev 00 Mometasone furoate monohydrate, Micronised | Mar 2026 | Inspected Dec 2025 Italy |
| BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang | CN | CEP 2025-357 - Rev 00 Mometasone furoate monohydrate, Micronised and non-micronised | Feb 2026 | — |
| NEWCHEM S.p.A. Milano | IT | CEP 2024-348 - Rev 01 Mometasone furoate monohydrate, Crystalline Form, micronised | Oct 2025 | — |
| SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze | CN | CEP 2024-044 - Rev 00 Mometasone furoate | Jun 2025 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2018-290 - Rev 02 Mometasone furoate monohydrate, Micronised | Jun 2025 | — |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2021-233 - Rev 02 Mometasone furoate monohydrate | May 2025 | — |
| AURISCO PHARMACEUTICAL CO., LTD. Tiantai | CN | CEP 2008-094 - Rev 05 Mometasone furoate | Apr 2025 | Inspected Dec 2023 Germany |
| AARTI PHARMALABS LIMITED Mulund (W), Mumbai | IN | CEP 2018-303 - Rev 03 Mometasone furoate monohydrate, Micronised | Mar 2025 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | CEP 2018-297 - Rev 04 Mometasone furoate, Micronised, alternative process | Mar 2025 | Inspected Jul 2026 Italy |
| TAPI NL B.V. Amsterdam | NL | CEP 2022-287 - Rev 02 Mometasone furoate monohydrate | Mar 2025 | — |
| HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang | CN | CEP 2024-339 - Rev 00 Mometasone furoate | Feb 2025 | — |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | CEP 2024-282 - Rev 00 Mometasone furoate monohydrate, Micronised | Oct 2024 | — |
| SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai | IN | CEP 2023-269 - Rev 00 Mometasone furoate monohydrate | Sept 2024 | — |
| HOVIONE FARMACIENCIA S.A. Loures | PT | CEP 2018-121 - Rev 03 Mometasone furoate monohydrate, Process I | Oct 2023 | Inspected Apr 2025 Portugal |
| AVIK PHARMACEUTICAL LIMITED Vapi | IN | R1-CEP 2008-221 - Rev 03 Mometasone furoate | Jun 2022 | — |
| SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Butterworth | MY | R0-CEP 2021-006 - Rev 00 Mometasone furoate monohydrate | Feb 2022 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | R1-CEP 2005-163 - Rev 02 Mometasone furoate | Aug 2021 | — |
| SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Perai | MY | R1-CEP 2009-313 - Rev 01 Mometasone furoate | Oct 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Mometasone Furoate are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- HUNAN YUXIN PHARMACEUTICAL CO LTDInactive DMF 25958 · filed Mar 2012
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (21 listed products contain Mometasone Furoate). The latest listed patent expires 24 Nov 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Mometasone Furoate is a synthetic corticosteroid with anti-inflammatory and antipruritic properties. It is commonly used in the treatment of skin conditions and allergic rhinitis.
Chemical identity
- IUPAC name
- [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
- Canonical SMILES
- C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C
- InChIKey
- WOFMFGQZHJDGCX-ZULDAHANSA-N
- Synonyms
- Nasonex API, asmanex, dulera component mometasone furoate, elocon, lyr-210, lyr210, mometasone furoate anhydrous, nsc-746171, nsc-760077, sch 32088, sch-32088, sinuva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Mometasone Furoate?
24 organisations hold an active US FDA Type II Drug Master File or a CEP for Mometasone Furoate: AARTI PHARMALABS LIMITED (India), CORAL DRUGS PVT LTD (India), STERLING SPA (Italy), BREATHGREEN PHARMACEUTICAL CO LTD, Cipla Limited (India), Farmabios S.p.A. (Italy), NEWCHEM SPA (Italy) and SYMBIOTEC PHARMALAB PRIVATE LTD (India), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Mometasone Furoate Drug Master Files are active?
AARTI PHARMALABS LIMITED (DMF 21334, 27956), CORAL DRUGS PVT LTD (DMF 30852, 31076), STERLING SPA (DMF 27022, 16648), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 39302, 39303), Cipla Limited (DMF 20969, 41355), Farmabios S.p.A. (DMF 22319, 33446), NEWCHEM SPA (DMF 42344, 21993) and SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 20684, 19781) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Mometasone Furoate records mean?
1 organisation has only inactive Type II DMFs for Mometasone Furoate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Mometasone Furoate have a European Certificate of Suitability?
Yes. 21 organisations hold a valid CEP for Mometasone Furoate on the EDQM register, including ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), INDUSTRIALE CHIMICA S.R.L. Saronno (IT), TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa (IL), SYMBIOTEC PHARMALAB LIMITED Indore (IN), STERLING S.p.A. Corciano (IT) and BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang (CN) and 16 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Mometasone Furoate?
Yes. The latest patent listed for an approved US product containing Mometasone Furoate expires 24 Nov 2034, across 21 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Mometasone Furoate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Mometasone Furoate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.